FNY Investment Advisers’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-203
Closed -$36K – 741
2023
Q2
$36K Buy
+203
New +$37.1K 0.05% 189
2022
Q1
– Sell
-368
Closed -$68K – 883
2021
Q4
$68K Hold
368
– – 0.04% 234
2021
Q3
$117K Sell
368
-285
-44% -$129K 0.05% 208
2021
Q2
$378K Buy
+653
New +$358K 0.15% 119

Other funds holding EDVA

FNY Investment Advisers's EDVA Position: Q3 2023 in Review

FNY Investment Advisers sold out of Endovia Health Sciences, Inc. (EDVA) in Q3 2023, closing a stake of 203 shares — an estimated $36K sold.

FNY Investment Advisers first reported a position in EDVA in Q2 2021 and held it in 4 quarters. The position peaked at $378K in Q2 2021. 26 funds tracked by Wall St. Rank hold EDVA as of Q3 2023.

  • FNY Investment Advisers reported no remaining Endovia Health Sciences, Inc. position as of Q3 2023 after selling out during the quarter.
  • FNY Investment Advisers sold 203 Endovia Health Sciences, Inc. shares in Q3 2023, an estimated $36K.
  • FNY Investment Advisers first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 4 quarters.
  • FNY Investment Advisers's Endovia Health Sciences, Inc. position peaked at $378K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.